Hepatic Failure/GI/Endocrine Emergencies
doi.org/10.1177/1060028019833696
Sachar H, Vaidya K, Laine L. Intermittent vs con-
tinuous proton pump inhibitor therapy for high-risk
bleeding ulcers: a systematic review and meta-analy-
doi.org/10.1001/jamainternmed.2014.4056
Saltzman JR, Tabak YP, Hyett BH, Sun X, Travis AC,
Johannes RS. A simple risk score accurately predicts in-
hospital mortality, length of stay, and cost in acute upper
GI bleeding. Gastrointest Endosc. 2011;74(6):1215-1224.
https://doi.org/10.1016/j.gie.2011.06.024
Srygley FD, Gerardo CJ, Tran T, Fisher DA. Does
this patient have a severe upper gastrointestinal
org/10.1001/jama.2012.253
Sung JJ, Lau JY, Ching JY, et al. Continuation of
low-dose aspirin therapy in peptic ulcer bleeding: a ran-
doi.org/10.7326/0003-4819-152-1-201001050-00179
Villanueva C, Colomo A, Bosch A, et al. Transfusion
strategies for acute upper gastrointestinal bleeding. N
Engl J Med. 2013;368(1):11-21. https://doi.org/10.1056/
nejmoa1211801
Witt DM, Delate T, Garcia DA, et al. Risk of thromboem-
bolism, recurrent hemorrhage, and death after warfarin
therapy interruption for gastrointestinal tract bleed-
ing. Arch Intern Med. 2012;172(19):1484-1491. https://
doi.org/10.1001/archinternmed.2012.4261
Wuerth BA, Rockey DC. Changing epidemiology of
upper gastrointestinal hemorrhage in the last decade: a
nationwide analysis. Dig Dis Sci. 2018;63(5):1286-1293.
https://doi.org/10.1007/s10620-017-4882-6
Endocrine Emergencies
American Diabetes Association. 13. Diabetes care in
the hospital, nursing home, and skilled nursing facil-
ity. Diabetes Care. 2015;38 Suppl:S80-S85. https://doi.
org/10.2337/dc15-s016
Annane D, Pastores SM, Rochwerg B, et al. Guidelines
for the diagnosis and management of critical illness-
related corticosteroid insufficiency (CIRCI) in critically
https://doi.org/10.1097/ccm.0000000000002737
Bornstein SR. Predisposing factors for adrenal insuffi-
ciency. N Engl J Med. 2009;360(22):2328-2339. https://
doi.org/10.1056/nejmra0804635
Brunkhorst FM, Engel C, Bloos F, et al. Intensive
insulin therapy and pentastarch resuscitation in severe
sepsis. N Engl J Med. 2008;358(2):125-139. https://doi.
org/10.1056/nejmoa070716
Burch HB, Cooper DS. Management of Graves disease:
org/10.1001/jama.2015.16535
Cooper DS. Antithyroid drugs. N Engl J Med.
2005;352(9):905-917.
https://doi.org/10.1056/
nejmra042972
Cooper MS, Stewart PM. Corticosteroid insufficiency in
acutely ill patients. N Engl J Med. 2003;348(8):727-734.
https://doi.org/10.1056/nejmra020529
Cryer
PE.
Mechanisms
of
hypoglycemia-asso-
ciated autonomic failure in diabetes. N Engl J
Med.
2013;369(4):362-372.
https://doi.org/10.1056/
nejmra1215228
Cryer PE, Axelrod L, Grossman AB, et al. Evaluation
and management of adult hypoglycemic disorders: an
Endocrine Society Clinical Practice Guideline. J Clin
Endocrinol Metab. 2009;94(3):709-728. https://doi.
org/10.1210/jc.2008-1410
Devereaux D, Tewelde SZ. Hyperthyroidism and thyro-
toxicosis. Emerg Med Clin North Am. 2014;32(2):277-292.
https://doi.org/10.1016/j.emc.2013.12.001
Dubbs SB, Spangler R. Hypothyroidism: causes, kill-
ers, and life-saving treatments. Emerg Med Clin
North Am. 2014;32(2):303-317. https://doi.org/10.1016/j.
emc.2013.12.003
ElSayed NA, Aleppo G, Aroda VR, et al. 16. Diabetes
care in the hospital: standards of care in diabe-
tes—2023. Diabetes Care. 2023;46(Suppl 1):S267-S278.
https://doi.org/10.2337/dc23-s016
Honarmand K, Sirimaturos M, Hirshberg EL, et al.
cemic control for critically ill children and adults
org/10.1097/ccm.0000000000006174
Jaber S, Paugam C, Futier E, et al. Sodium bicarbon-
ate therapy for patients with severe metabolic acidaemia
in the intensive care unit (BICAR-ICU): a multicen-
tre, open-label, randomised controlled, phase 3 trial.